- Home
- ATNM vs LXEH Comparison
ATNM vs LXEH Comparison
Compare ATNM & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- LXEH
- Stock Information
- Founded
- ATNM 2000
- LXEH 2001
- Country
- ATNM United States
- LXEH China
- Employees
- ATNM N/A
- LXEH N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- LXEH Other Consumer Services
- Sector
- ATNM Health Care
- LXEH Real Estate
- Exchange
- ATNM Nasdaq
- LXEH Nasdaq
- Market Cap
- ATNM 50.2M
- LXEH 55.2M
- IPO Year
- ATNM N/A
- LXEH 2020
- Fundamental
- Price
- ATNM $1.61
- LXEH $2.43
- Analyst Decision
- ATNM Strong Buy
- LXEH
- Analyst Count
- ATNM 2
- LXEH 0
- Target Price
- ATNM $4.50
- LXEH N/A
- AVG Volume (30 Days)
- ATNM 122.2K
- LXEH 4.3M
- Earning Date
- ATNM 11-13-2025
- LXEH 09-26-2025
- Dividend Yield
- ATNM N/A
- LXEH N/A
- EPS Growth
- ATNM N/A
- LXEH N/A
- EPS
- ATNM N/A
- LXEH N/A
- Revenue
- ATNM N/A
- LXEH $4,493,795.00
- Revenue This Year
- ATNM N/A
- LXEH N/A
- Revenue Next Year
- ATNM N/A
- LXEH N/A
- P/E Ratio
- ATNM N/A
- LXEH N/A
- Revenue Growth
- ATNM N/A
- LXEH N/A
- 52 Week Low
- ATNM $1.03
- LXEH $1.12
- 52 Week High
- ATNM $2.41
- LXEH $50.08
- Technical
- Relative Strength Index (RSI)
- ATNM 45.72
- LXEH 63.64
- Support Level
- ATNM $1.60
- LXEH $2.26
- Resistance Level
- ATNM $1.70
- LXEH $2.69
- Average True Range (ATR)
- ATNM 0.07
- LXEH 0.22
- MACD
- ATNM -0.01
- LXEH 0.04
- Stochastic Oscillator
- ATNM 32.14
- LXEH 73.20
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.